https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Oral cancer in Australia: Rising incidence and worsening mortality https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53336 Wed 28 Feb 2024 16:23:52 AEDT ]]> Bayesian Disease Mapping to Identify High-Risk Population for Oral Cancer: A Retrospective Spatiotemporal Analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53594 Wed 28 Feb 2024 15:58:37 AEDT ]]> Barriers to Oral Health Care for Autistic Individuals—A Scoping Review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54804 Wed 13 Mar 2024 14:43:56 AEDT ]]> Next-Generation Vaccines for Tropical Infectious Diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55126 Thu 11 Apr 2024 11:13:46 AEST ]]> Effect of xylitol on Porphyromonas gingivalis: A systematic review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53438 Mon 27 Nov 2023 11:47:56 AEDT ]]> Effect of Bergenin on Human Gingival Fibroblast Response on Zirconia Implant Surfaces: An In Vitro Study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53243 0.05) tested. In conclusion, bergenin is non-cytotoxic and is potentially safe to be used as a local pharmacological agent for the management of peri-implant inflammatory diseases.]]> Mon 20 Nov 2023 10:15:24 AEDT ]]> Predicting oral cancer survival—Development and validation of an Asia-Pacific nomogram https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51577 Mon 11 Sep 2023 14:29:52 AEST ]]>